HRP960395B1 - Zwitterionic forms of trovafloxacin - Google Patents

Zwitterionic forms of trovafloxacin

Info

Publication number
HRP960395B1
HRP960395B1 HR960395A HRP960395A HRP960395B1 HR P960395 B1 HRP960395 B1 HR P960395B1 HR 960395 A HR960395 A HR 960395A HR P960395 A HRP960395 A HR P960395A HR P960395 B1 HRP960395 B1 HR P960395B1
Authority
HR
Croatia
Prior art keywords
trovafloxacin
zwitterionic forms
zwitterionic
forms
Prior art date
Application number
HR960395A
Other languages
English (en)
Inventor
John Meldrum Allen Douglas
David Joseph Bruning
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HRP960395A2 publication Critical patent/HRP960395A2/xx
Publication of HRP960395B1 publication Critical patent/HRP960395B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
HR960395A 1995-08-29 1996-08-29 Zwitterionic forms of trovafloxacin HRP960395B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (2)

Publication Number Publication Date
HRP960395A2 HRP960395A2 (en) 1998-06-30
HRP960395B1 true HRP960395B1 (en) 2001-12-31

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
HR960395A HRP960395B1 (en) 1995-08-29 1996-08-29 Zwitterionic forms of trovafloxacin

Country Status (30)

Country Link
EP (1) EP0850060A1 (sh)
JP (1) JP3188476B2 (sh)
KR (1) KR100343909B1 (sh)
CN (1) CN1190889A (sh)
AP (1) AP636A (sh)
AR (1) AR003985A1 (sh)
AU (1) AU704115B2 (sh)
BR (1) BR9609998A (sh)
CA (1) CA2229786C (sh)
CO (1) CO4480739A1 (sh)
CZ (1) CZ56698A3 (sh)
DZ (1) DZ2087A1 (sh)
GT (1) GT199600072A (sh)
HR (1) HRP960395B1 (sh)
HU (1) HUP9900170A3 (sh)
IL (1) IL122651A (sh)
MA (1) MA23966A1 (sh)
MY (1) MY113874A (sh)
NO (1) NO309814B1 (sh)
NZ (1) NZ312199A (sh)
OA (1) OA10669A (sh)
PE (1) PE12598A1 (sh)
PL (1) PL325170A1 (sh)
RU (1) RU2144921C1 (sh)
SK (1) SK23898A3 (sh)
TN (1) TNSN96109A1 (sh)
TR (1) TR199800339T1 (sh)
WO (1) WO1997007800A1 (sh)
YU (1) YU48396A (sh)
ZA (1) ZA967282B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
ZA967282B (en) 1998-03-02
JPH10511692A (ja) 1998-11-10
KR19990044232A (ko) 1999-06-25
MY113874A (en) 2002-06-29
EP0850060A1 (en) 1998-07-01
AU6367696A (en) 1997-03-19
IL122651A0 (en) 1998-08-16
JP3188476B2 (ja) 2001-07-16
CA2229786A1 (en) 1997-03-06
AR003985A1 (es) 1998-09-30
HUP9900170A3 (en) 1999-11-29
AP636A (en) 1998-04-09
AP9600853A0 (en) 1996-10-31
CO4480739A1 (es) 1997-07-09
NO980862D0 (no) 1998-02-27
MX9801664A (es) 1998-08-30
IL122651A (en) 2000-02-17
WO1997007800A1 (en) 1997-03-06
NO309814B1 (no) 2001-04-02
YU48396A (sh) 1998-12-23
BR9609998A (pt) 1999-07-06
TR199800339T1 (xx) 1998-06-22
OA10669A (en) 2000-11-06
PL325170A1 (en) 1998-07-06
NO980862L (no) 1998-02-27
TNSN96109A1 (fr) 2005-03-15
GT199600072A (es) 1998-02-14
PE12598A1 (es) 1998-03-20
KR100343909B1 (ko) 2003-04-10
MA23966A1 (fr) 1997-04-01
DZ2087A1 (fr) 2002-07-22
HUP9900170A2 (hu) 1999-05-28
HRP960395A2 (en) 1998-06-30
RU2144921C1 (ru) 2000-01-27
AU704115B2 (en) 1999-04-15
CA2229786C (en) 2002-02-19
CN1190889A (zh) 1998-08-19
NZ312199A (en) 1999-06-29
CZ56698A3 (cs) 1999-02-17
SK23898A3 (en) 1999-05-07

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
PL327569A1 (en) Promedications of thrombosin inhibitors
AU4780596A (en) Hemi-wheeled walker
GB9526560D0 (en) Use of 2-Amino-Heterocycles
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
GB9512290D0 (en) Uses of polyhexanide
IL116924A (en) Preparation of n-aryl - and n-hetarylhydroxylamines
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
NZ312199A (en) Zwitterionic forms of trovafloxacin
IL113228A (en) Derivatives of anandamide
GB9600205D0 (en) Interferometer
IL117786A (en) Preparation of alpha-bisoximes
GB9502673D0 (en) Combined shower
AU6171196A (en) Therapeutic uses of ta99
AU4053295A (en) Shower spa
ZA962440B (en) Destressing of railtracks
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
GB9514072D0 (en) Preparation of thionucleosides
IL115554A0 (en) Earthquake-proofing of structures
CA76199S (en) Set of dishes
HU9502606D0 (en) New intermediers of ace-inhibitors
HRP950468A2 (en) New medicine - combination of components
PL311976A1 (en) Closed-profile shape of double-o type
GB9503734D0 (en) Manufacture of polyanlines
GB9509653D0 (en) Walker

Legal Events

Date Code Title Description
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
A1OB Publication of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20020829

Year of fee payment: 7

PBON Lapse due to non-payment of renewal fee

Effective date: 20030830